Inhibition of Duck Hepatitis B Virus Replication by 2',3'-Dideoxy-3'-Fluoroguanosine In Vitro and In Vivo (English)
- New search for: Hafkemeyer, P.
- New search for: Keppler-Hafkemeyer, A.
- New search for: Al Haya, M. A.
- New search for: Von Janta-Lipinski, M.
- New search for: Matthes, E.
- New search for: Lehmann, C.
- New search for: Offensperger, W.-B.
- New search for: Offensperger, S.
- New search for: Gerok, W.
- New search for: Blum, H. E.
- New search for: Hafkemeyer, P.
- New search for: Keppler-Hafkemeyer, A.
- New search for: Al Haya, M. A.
- New search for: Von Janta-Lipinski, M.
- New search for: Matthes, E.
- New search for: Lehmann, C.
- New search for: Offensperger, W.-B.
- New search for: Offensperger, S.
- New search for: Gerok, W.
- New search for: Blum, H. E.
In:
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY -JOURNAL-
;
40
, 3
;
792-794
;
1996
-
ISSN:
- Article (Journal) / Print
-
Title:Inhibition of Duck Hepatitis B Virus Replication by 2',3'-Dideoxy-3'-Fluoroguanosine In Vitro and In Vivo
-
Contributors:Hafkemeyer, P. ( author ) / Keppler-Hafkemeyer, A. ( author ) / Al Haya, M. A. ( author ) / Von Janta-Lipinski, M. ( author ) / Matthes, E. ( author ) / Lehmann, C. ( author ) / Offensperger, W.-B. ( author ) / Offensperger, S. ( author ) / Gerok, W. ( author ) / Blum, H. E. ( author )
-
Published in:ANTIMICROBIAL AGENTS AND CHEMOTHERAPY -JOURNAL- ; 40, 3 ; 792-794
-
Publisher:
- New search for: AMERICAN SOCIETY FOR MICROBIOLOGY
-
Publication date:1996-01-01
-
Size:3 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 615.329 / 615
- Further information on Dewey Decimal Classification
-
Classification:
-
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 40, Issue 3
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 527
-
Mechanisms of Nucleoside Analog Antiviral Activity and Resistance during Human Immunodeficiency Virus Reverse TranscriptionArts, Eric J. et al. | 1996
- 541
-
Susceptibility of Melanized and Nonmelanized Cryptococcus neoformans to the Melanin-Binding Compounds Trifluoperazine and ChloroquineWang, Yulin et al. | 1996
- 546
-
Activities of Bay Y 3118, Levofloxacin, and Ofloxacin Alone or in Combination with Ethambutol against Mycobacterium avium Complex In Vitro, in Human Macrophages, and in Beige MiceBermudez, Luiz E. et al. | 1996
- 552
-
Preventive Chemotherapy of Tuberculosis in Cornell Model Mice with Combinations of Rifampin, Isoniazid, and PyrazinamideDhillon, Jasvir et al. | 1996
- 556
-
Single-Dose and Steady-State Pharmacokinetics of a Novel Microfluidized Suspension of Atovaquone in Human Immunodeficiency Virus-Seropositive PatientsDixon, R. et al. | 1996
- 561
-
Pharmacokinetics of Trovafloxacin (CP-99,219), a New Quinolone, in Rats, Dogs, and MonkeysTeng, Renli et al. | 1996
- 567
-
Influence of Maturation and Growth on Cefetamet Pivoxil Pharmacokinetics: Rational Dosing for InfantsHayton, William L. et al. | 1996
- 575
-
Factors Influencing Elimination and Distribution of Fleroxacin: Metaanalysis of Individual Data from 10 Pharmacokinetic StudiesReigner, B.G. et al. | 1996
- 581
-
The Macrolide-Lincosamide-Streptogramin B Resistance Phenotypes Characterized by Using a Specifically Deleted, Antibiotic-Sensitive Strain of Streptomyces lividansPernodet, Jean-Luc et al. | 1996
- 586
-
Activity of Oral Atovaquone Alone and in Combination with Antimony in Experimental Visceral LeishmaniasisMurray, Henry W. et al. | 1996
- 588
-
Susceptibilities of Candida spp. to Antifungal Agents Visualized by Two-Dimensional Scatterplots of Relative GrowthOdds, F.C. et al. | 1996
- 595
-
Stereospecific Reduction of Virginiamycin M1 as the Virginiamycin Resistance Pathway in Streptomyces virginiaeLee, Chang-Kwon et al. | 1996
- 602
-
Differential In Vitro Activities of Ionophore Compounds against Plasmodium falciparum and Mammalian CellsGumila, Catherine et al. | 1996
- 609
-
Pharmacokinetics of Conventional Formulation versus Fat Emulsion Formulation of Amphotericin B in a Group of Patients with NeutropeniaAyestarán, Ana et al. | 1996
- 613
-
Potential Use of WR6026 as Prophylaxis against Transfusion-Transmitted American TrypanosomiasisChiari, Egler et al. | 1996
- 616
-
Characterization of -Lactamase Gene bla~P~E~R~-~2, Which Encodes an Extended-Spectrum Class A -LactamaseBauernfeind, A. / Stemplinger, I. / Jungwirth, R. / Mangold, P. / Amann, S. / Akalin, E. / Ang, O. / Bal, C. / Casellas, J. M. et al. | 1996
- 616
-
Characterization of b-Lactamase Gene blaPER-2, Which Encodes an Extended-Spectrum Class A b-LactamaseBauernfeind, A. et al. | 1996
- 621
-
In Vitro Antibacterial Activity of Omeprazole and Its Selectivity for Helicobacter spp. Are Dependent on Incubation ConditionsSjöström, J.E. et al. | 1996
- 627
-
Twenty-Four-Hour Area under the Concentration-Time Curve-MIC Ratio as a Generic Predictor of Fluoroquinolone Antimicrobial Effect by Using Three Strains of Pseudomonas aeruginosa and an In Vitro Pharmacodynamic ModelMadaras-Kelly, Karl J. et al. | 1996
- 633
-
Antituberculosis Activities of Clofazimine and Its New Analogs B4154 and B4157Reddy, Venkata M. et al. | 1996
- 637
-
Amphotericin B Enzyme-Linked Immunosorbent AssayCleary, John D. et al. | 1996
- 642
-
Pharmacokinetics of (-)-2'-3'-Dideoxy-3'-Thiacytidine in WoodchucksRajagopalan, Prabhu et al. | 1996
- 646
-
Rifampin Resistance in Neisseria meningitidis Due to Alterations in Membrane PermeabilityAbadi, Fariborz J.R. et al. | 1996
- 652
-
Transport of the Antibacterial Agent Oxazolidin-2-One and Derivatives across Intestinal (Caco-2) and Renal (MDCK) Epithelial Cell LinesRanaldi, Giulia et al. | 1996
- 659
-
Pharmacokinetics of [^1^8F]Fleroxacin in Patients with Acute Exacerbations of Chronic Bronchitis and Complicated Urinary Tract Infection Studied by Positron Emission TomographyFischman, A. J. / Livni, E. / Babich, J. W. / Alpert, N. M. / Bonab, A. / Chodosh, S. / McGovern, F. / Kamitsuka, P. / Liu, Y.-Y. / Cleeland, R. et al. | 1996
- 659
-
Pharmacokinetics of (18F)FIeroxacin in Patients with Acute Exacerbations of Chronic Bronchitis and Complicated Urinary Tract Infection Studied by Positron Emission TomographyFischman, Alan J. et al. | 1996
- 665
-
Eradication of Mucoid Pseudomonas aeruginosa with Fluid Liposome-Encapsulated Tobramycin in an Animal Model of Chronic Pulmonary InfectionBeaulac, Christian et al. | 1996
- 670
-
Effects of Fasting on Temporal Variations in Nephrotoxicity of Gentamicin in RatsBeauchamp, Denis et al. | 1996
- 677
-
Comparison of Methodologies for Synergism Testing of Drug Combinations against Resistant Strains of Pseudomonas aeruginosaCappelletty, Diane M. et al. | 1996
- 684
-
Activity and Mode of Action of Acridine Compounds against Leishmania donovaniMesa-Valle, C.M. et al. | 1996
- 691
-
Continuous Infusion versus Intermittent Administration of Ceftazidime in Critically Ill Patients with Suspected Gram-Negative InfectionsBenko, Amy S. et al. | 1996
- 696
-
Comparison of Conventional Dosing versus Continuous-Infusion Vancomycin Therapy for Patients with Suspected or Documented Gram-Positive InfectionsJames, Joseph K. et al. | 1996
- 701
-
Pharmacodynamics of Once- or Twice-Daily Levofloxacin versus Vancomycin, with or without Rifampin, against Staphylococcus aureus in an In Vitro Model with Infected Platelet-Fibrin ClotsPalmer, Shirley M. et al. | 1996
- 706
-
Effect of Mitonafide Analogs on Topoisomerase II of Leishmania chagasiMiller Slunt, Kelli et al. | 1996
- 706
-
Effect of Mitonafide Analogs on Topoisomerase II of Leishrnania chagasiSlunt, K. M. / Grace, J. M. / Macdonald, T. L. / Pearson, R. D. et al. | 1996
- 710
-
Quinolone-Resistant Mutants of Escherichia coli DNA Topoisomerase IV parC GeneKumagai, Yumi et al. | 1996
- 715
-
Characterization of the Chromosomal Cephalosporinases Produced by Acinetobacter lwoffii and Acinetobacter baumannii Clinical IsolatesPerilli, M. / Felici, A. / Oratore, A. / Cornaglia, G. / Bonfiglio, G. / Rossolini, G. M. / Amicosante, G. et al. | 1996
- 715
-
Characterization of the Chromosomal Cephalosporinases Produced by Acinetobacter Iwoffii and Acinetobacter baumannii Clinical IsolatesPerilli, Mariagrazia et al. | 1996
-
In Vitro Antimicrobial Activities and Spectra of U-100592 and U-100766, Two Novel Fluorinated OxazolidinonesJones, Ronald N. et al. | 1996
- 727
-
Identification of a Class of Sulfonamides Highly Active against Dihydropteroate Synthase from Toxoplasma gondii, Pneumocystis carinii, and Mycobacterium aviumChio, Li-Chun et al. | 1996
- 734
-
Predictors of Effect of Ampicillin-Sulbactam against TEM-1 b-Lactamase-Producing Escherichia coli in an In Vitro Dynamic Model: Enzyme Activity versus MICFirsov, Alexander A. et al. | 1996
- 734
-
Predictors of Effect of Ampicillin-Sulbactam against TEM-1 -Lactamase-Producing Escherichia coli in an In Vitro Dynamic Model: Enzyme Activity versus MICFirsov, A. A. / Savarino, D. / Ruble, M. / Gilbert, D. / Manzano, B. / Medeiros, A. A. / Zinner, S. H. et al. | 1996
- 739
-
Uptake and Intracellular Activity of NM394, a New Quinolone, in Human Polymorphonuclear LeukocytesOzaki, Masakuni et al. | 1996
- 743
-
In Vitro Activities of Rifabutin, Azithromycin, Ciprofloxacin, Clarithromycin, Clofazimine, Ethambutol, and Amikacin in Combinations of Two, Three, and Four Drugs against Mycobacterium aviumYajko, David M. et al. | 1996
- 750
-
Antiviral Efficacy In Vivo of the Anti-Human Immunodeficiency Virus Bicyclam SDZ SID 791 (JM 3100),n Inhibitor of Infectious Cell EntryDatema, Roelf et al. | 1996
- 750
-
Antiviral Efficacy In Vivo of the Anti-Human Immunodeficiency Virus Bicyclam SDZ SID 791 (JM 3100), an Inhibitor of Infectious Cell EntryDatema, R. / Rabin, L. / Hincenbergs, M. / Moreno, M. B. / Warren, S. / Linquist, V. / Rosenwirth, B. / Seifert, J. / McCune, J. M. et al. | 1996
- 755
-
Use of Standardized SCID-hu Thy-Liv Mouse Model for Preclinical Efficacy Testing of Anti-Human Immunodeficiency Virus Type 1 CompoundsRabin, Linda et al. | 1996
- 763
-
Cerebrospinal Fluid Ceftazidime Kinetics in Patients with External VentriculostomiesNau, R. et al. | 1996
- 767
-
Didanosine Reduces Atevirdine Absorption in Subjects with Human Immunodeficiency Virus InfectionsMorse, Gene D. et al. | 1996
- 772
-
Susceptibilities of Non-Pseudomonas aeruginosa Gram-Negative Nonfermentative Rods to Ciprofloxacin, Ofloxacin, Levofloxacin, D-Ofloxacin, Sparfloxacin, Ceftazidime, Piperacillin, Piperacillin-Tazobactam, Trimethoprim-Sulfamethoxazole, and ImipenemSpangler, Sheila K. et al. | 1996
- 776
-
Pharmacokinetics of Sparfloxacin and Serum Bactericidal Activity against PneumococciTrautmann, M. et al. | 1996
- 780
-
Penetration of Cefetamet Pivoxil and Cefuroxime Axetil into the Maxillary Sinus Mucosa at Steady StateStoeckel, Klaus et al. | 1996
- 784
-
Alteration of Postantibiotic Effect during One Dosing Interval of Tobramycin, Simulated in an In Vitro Pharmacokinetic ModelHollander, Jan G.den et al. | 1996
- 787
-
Penetration of Ciprofloxacin and Fleroxacin into Biliary TractEdmiston Jr, Charles E. et al. | 1996
- 789
-
Pharmacokinetics of Oral Fleroxacin in Male and Premenopausal Female VolunteersBertino Jr, Joseph S. et al. | 1996
- 792
-
Inhibition of Duck Hepatitis B Virus Replication by 2',3'-Dideoxy-3'-Fluoroguanosine In Vitro and In VivoHafkemeyer, Peter et al. | 1996
- 795
-
Pharmacokinetics in Nonhuman Primates of a Prototype Carbapenem Active against Methicillin-Resistant Staphylococcus aureusSundelof, J.G. et al. | 1996
- 799
-
In Vitro Activities of Oxazolidinone Compounds U100592 and U100766 against Staphylococcus aureus and Staphylococcus epidermidisKaatz, Glenn W. et al. | 1996
- 802
-
Temporal Variation in Nephrotoxicity of Low Doses of Isepamicin in RatsYoshiyama, Yuji et al. | 1996
- 807
-
In Vitro Susceptibilities of Bordetella pertussis and Bordetella parapertussis to Four Fluoroquinolones (Levofloxacin, d-Ofloxacin, Ofloxacin, and Ciprofloxacin), Cefpirome, and MeropenemHoppe, Jörg E. et al. | 1996
- 809
-
Efficacy of Clarithromycin versus That of Clindamycin for Single-Dose Prophylaxis of Experimental Streptococcal EndocarditisVermot, D. et al. | 1996
- 812
-
Penetration of Ceftriaxone (1 or 2 Grams Intravenously) into Mediastinal and Cardiac Tissues in HumansMartin, Claude et al. | 1996
- 816
-
Bleomycin Therapy of Experimental Disseminated Candidiasis in MiceGraybill, John R. et al. | 1996
- 819
-
Influence of Experimental Rat Model of Multiple Organ Dysfunction on Cefepime and Amikacin PharmacokineticsMimoz, O. et al. | 1996
- 822
-
In Vitro Susceptibilities of Clinical and Environmental Isolates of Cryptococcus neoformans to Five Antifungal DrugsFranzot, Sarah P. et al. | 1996
- 825
-
Distribution of Azithromycin into Brain Tissue, Cerebrospinal Fluid, and Aqueous Humor of the EyeJaruratanasirikul, Sutep et al. | 1996
- 827
-
Management of Meningitis Caused by Penicillin-Resistant Streptococcus pneumoniaeBhattacharya, S. et al. | 1996